期刊文献+

CTLA-4Ig融合蛋白对ApoE基因缺陷小鼠动脉粥样硬化的抑制作用

Inhibitory Effect of CTLA-4Ig Fusion Protein on Atherosclerosis in ApoE^(-/-) Mice
下载PDF
导出
摘要 【目的】探讨CTLA-4Ig融合蛋白对高脂饮食饲养的载脂蛋白E基因缺陷小鼠(ApoE-/-)动脉粥样硬化病变的抑制作用。【方法】25只10周龄ApoE-/-小鼠,高脂饮食饲养4周后,随机取5只验证AS病变(对照组);剩余20只随机分为4组(每组5只),继续高脂饮食饲养,分别采用CTLA-4Ig、PBS、IgG1腹腔注射,第4组不予处理;8周后取小鼠主动脉进行病理学检查,检测AS相关指标,包括斑块面积/管腔面积比、血管内膜/中膜厚度比,斑块内脂质、胶原和平滑肌细胞含量。【结果】高脂饮食饲养4周后,出现明显AS病变。继续高脂饮食饲养8周,形成典型AS斑块,CTLA-4Ig组、PBS组、IgG1组和空白组的斑块面积/管腔面积比分别为0.27±0.08、0.40±0.08、0.43±0.08和0.46±0.10,较4周时(0.05±0.01)明显增加(P<0.05),4组的血管内膜/中膜厚度比分别为2.6±0.6、6.0±0.9、5.7±0.8和5.9±0.6,高于对照组(0.5±0.1,P<0.05),4组斑块内脂质含量(%)分别为26.0±3.0、40.8±5.7、40.6±3.0和43.2±5.7较4周时明显增加(7.2±1.4,P<0.05)。采用CTLA-4Ig进行干预后,其斑块面积/管腔面积比、血管内膜/中膜厚度比和斑块内脂质含量显著低于PBS、IgG1和空白处理组(P<0.05),而后3组间上述指标的差异无统计学意义(P>0.05);CTLA-4Ig组斑块内胶原含量(16.0±1.1)%高于其他3组[(8.6±1.2)%、(9.2±1.5)%和(9.0±1.3)%,P<0.05)],其斑块内平滑肌细胞含量(11.8±1.0)%明显高于其他3组[(7.8±0.8)%、(7.5±0.9)%和(7.3±0.7)%,P<0.05)],另外3组间上述指标的差异无统计学意义(P>0.05)。【结论】CTLA-4Ig融合蛋白能够阻抑高脂饮食饲养的ApoE-/-小鼠动脉粥样硬化进程,其增加斑块内血管平滑肌细胞生成胶原作用有助增加AS斑块的稳定性。 [ Objective ] To investigate the inhibitory effect of CTLA-4Ig fusion protein on atherosclerosis in the mice with an apolipoprotein-E gene defect fed on cholesterol diet. [Methods] Twenty-five male 10-week-old ApoE^-/- mice were selected and fed on cholesterol diet for 4 weeks, 5 out of which were executed at random as control group and their pathological sections were kept to observe the early fatty streaks. The other 20, divided into CTLA-4Ig treatment group, PBS group, IgG1 group, and blank group at random, 5 in each. Three groups were given intraperitoneal injection of CTLA-4Ig (10 μg per time), PBS (100 μL per time), Rat-IgG1 (10μg per time) respectively, twice a week, for 8 weeks. The blank group has no treatment. Followed by 8- week treatment, the whole aorta from the root to crotch of lilac artery was separated after anesthesia with the intraperitoneal injection of 1% pentobarbital. Subsequently, the area ratio of plaque and lumen, the thickness ratio of endangium and tunica media, the lipid-soaking extent intra-plaque and the content of collagen fibrils and smooth muscle cells intra-plaque were analyzed by image-processing soft. [ Results ] After fed on cholesterol diet for 4 weeks, there were obviously atherosclerosis in the aorta in the ApoE^-/- mice. There were typical atherosclerotic plaque in ApoE^-/- mice fed on cholesterol diet after another 8 weeks. The area ratios of plaque and lumen in CTLA-4Ig group, PBS group, IgG1 group, and blank group were 0.27 ± 0.08, 0.40 ± 0.08, 0.43 ± 0.08, and 0.46 ± 0.10, and obviously increased than those in control group (0.05 ± 0.01, P 〈 0.05). The thickness ratios of endangium and tunica media in four groups were 2.6 ± 0.6, 6.0 ± 0.9, 5.7 ± 0.8, and 5.9 ± 0.6 and obviously increased than those in control group (0.5 ± 0.1, P 〈 0.05). The lipid-soaking extent intra-plaque in experimental groups were 26.0 ± 3.0, 40.8 ± 5.7, 40.6 ± 3.0, and 43.2 ± 5.7, and were obviously increased than those in control group (7.2 ± 1.4, P 〈 0.05 ). It was found that the area ratio of plaque and lumen, the thickness ratio of endangium and tunica media, and the lipid-soaking extent intra-plaque in CTLA-4Ig group were significantly lower than those in PBS group, IgG1 group, and blank group (P 〈 0.05), but there was no significant difference in those between the PBS group, IgG1 group, and blank group (P 〉 0.05). The content of collagen fibrils in CTLA-4Ig group were 16.0 ± 1.1 and higher than those in PBS group, IgG1 group, and blank group (8.6 ± 1.2, 9.2 ± 1.5, and 9.0 ± 1.3, P 〈 0.05). The content of smooth muscle cells in plaque in CTLA-4Ig group were 11.8 ± 1.0 and higher than those in PBS group, IgG1 group, and blank group (7.8 ±0.8, 7.5 ± 0.9, and 7.3 ± 0.7, P 〈 0.05). There was no significant difference in content of collagen fibrils and smooth muscle cells between the PBS group, IgG1 group, and blank group (all P 〉 0.05). [Conclusion] CTLA-4Ig fusion protein could evidently inhibit the atherosclerosis progression and enhance the stability of plaque through increasing the content of collagen fibrils produced by smooth muscle cells intra-plaque in ApoE^-/- mice fed on cholesterol diet.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2009年第4期395-399,417,共6页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广东省自然科学基金(07001655) 广东省科技计划项目(2006B36007003)
关键词 动脉粥样硬化 B7/CD28 CTLA-4 CTLA-4IG 载脂蛋白E基因缺陷小鼠 atherosclerosis B7/CD28 : CTLA-4 CTLA-4Ig ApoE^-/- mice
  • 相关文献

参考文献17

  • 1Ross R.Atherosclerosis-an inflammatory disease[J].N Engl J Med,1999,340(2):115-126.
  • 2Hansson GK.Immune Mechanisms in Atherosclerosis[J].Arterioscler Thromb Vasc Biol,2001,21(12):1876-1890.
  • 3Libby P.Inflammation in Atherosclerosis[J].Nature,2002,420(6917):868-874.
  • 4Greaves DR,Channon KM.Inflammation and Immune responses in atherosclerosis[J].Trends Immunol,2002,23(11):535-541.
  • 5McAdam AJ,Schwestzer AN,Sharpe AH.The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells[J].Immunol Rev,1998,165:231-247.
  • 6Afek A,Harats D,Roth A,et al.Evidence for the involvement of T cell costimulation through the B-7/CD28 pathway in atherosclerotic plaques from apolipoprotein E knockout mice[J].Exp Mol Pathol,2004,76(3):219-223.
  • 7Buono C,Pang H,Uchida Y,et al.B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice[J].Circulation,2004,109(16):2009-2015.
  • 8Buono C,Lichtman AH.Co-stimulation and plaque-antigen-specific T-cell responses in atherosclerosis[J].Trends Cardiovasc Med,2004,14(4):166-172.
  • 9战萍萍,李玉杰.共刺激分子CD40/CD40L及B7/CD28与动脉粥样硬化[J].国际内科学杂志,2007,34(8):467-470. 被引量:3
  • 10Linsley PS,Brady W,Grosmaire L,et al.Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleakin 2 mRNA accumulation[J].J Exp Med,1991,173(3):721-730.

二级参考文献17

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部